
Tirzepetide (Mounjaro)
Tirzepatide (Mounjaro) is an injection prescribed by clinicians to help with weight management in adults living with obesity. It works by acting on natural gut hormones that play a role in appetite and blood sugar control, helping you feel fuller for longer.2
Large clinical studies have shown that people using tirzepatide lost a significant amount of weight over 72 weeks, with many achieving 20% or more of their body weight compared to just a small change in those not on treatment.2 In the UK, it was approved for weight management in November 2023 by the MHRA, and it was later introduced to market in February 2024.